Signed Into Law
Signed June 20, 2025Effective 2025-09-01
SB269

Regular Session

Relating to required reports of certain vaccine-related or drug-related adverse events.

Government Affairs & Regulatory Compliance Analysis

Business Impact

Who SB269 Affects

Regulatory Priority: critical

Significant regulatory changes (effective 2025-09-01). Review with your legal and compliance teams to understand implications.

Estimated Cost Impact

Need Government Relations Support?

JD Key Consulting provides government affairs and regulatory strategy services. We help businesses navigate Texas agencies, understand legislative impacts, and advocate for their interests.

Need Help Navigating This Legislation?

JD Key Consulting provides strategic guidance on Texas regulatory compliance and legislative impact for your business.

01

Compliance Analysis

Key implementation requirements and action items for compliance with this legislation

Immediate Action Plan

Operational Changes Required

Strategic Ambiguities & Considerations

Need Compliance Guidance on This Legislation?

Schedule a Consultation

Information presented is for general knowledge only and is provided without warranty, express or implied. Consult qualified government affairs professionals and legal counsel before making compliance decisions.

02
03
Quick Reference

Frequently Asked Questions

Common questions about SB269

Q

What does Texas SB269 do?

Effective September 1, 2025, Texas physicians face a mandatory statutory duty to report serious adverse events linked to experimental, investigational, or Emergency Use Authorization (EUA) drugs and vaccines to federal databases (VAERS and MedWatch). This legislation transforms previously voluntary federal reporting into a state-enforced requirement, subjecting providers to Texas Medical Board (TMB) sanctions for non-compliance.

Q

Who authored SB269?

SB269 was authored by Texas Senator Charles Perry during the Regular Session.

Q

When was SB269 signed into law?

SB269 was signed into law by Governor Greg Abbott on June 20, 2025.

Q

Which agencies enforce SB269?

SB269 is enforced by Health and Human Services Commission and Texas Medical Board.

Q

How significant are the changes in SB269?

The regulatory priority for SB269 is rated as "critical". Businesses and organizations should review the legislation to understand potential impacts.

Q

What is the cost impact of SB269?

The cost impact of SB269 is estimated as "low". This may vary based on industry and implementation requirements.

Q

What topics does SB269 address?

SB269 addresses topics including health care providers, health, health--other diseases & medical conditions, electronic information systems and immunizations.

Q

What are the key dates for SB269?

Key dates for SB269: Effective date is 2025-09-01. Rulemaking: Adopt rules necessary to implement Section 161.0103 (Vaccines) and Section 431.1145 (Drugs) of the Health and Safety Code. (As soon as practicable after 2025-09-01). Consult with legal counsel regarding applicability.

Q

What are the penalties under SB269?

SB269 establishes the following penalties: administrative penalty of Non-disciplinary corrective action for Initial violation: Failure to report a qualifying serious adverse event to VAERS or MedWatch.; administrative penalty of Disciplinary action (subject to Subtitle B, Title 3, Occupations Code) for Subsequent violations: Failure to report a qualifying serious adverse event to VAERS or MedWatch.. Consult with legal counsel for specific applicability to your situation.

Q

Which Texas businesses are affected by SB269?

SB269 primarily affects healthcare providers and medical facilities. These businesses should review the legislation with their legal and compliance teams to understand potential impacts.

Legislative data provided by LegiScanLast updated: January 11, 2026